-
公开(公告)号:KR1020100079539A
公开(公告)日:2010-07-08
申请号:KR1020080138061
申请日:2008-12-31
Applicant: 서울대학교산학협력단
IPC: A61K31/202 , A61P3/04 , A23L1/30
Abstract: PURPOSE: A PEGylated conjugated linoeic acid(CLA) is provided to enhance solubility of CLA an d to improve biocompatibility. CONSTITUTION: A pharmaceutical composition having high anti-obesity activities contains phegylated linoleic acid(PCLA). The pharmaceutical composition further contains carrier, excipient, and diluent. A food composition contains linoleic acid as an active ingredient. The composition is used in the form of tablet, capsule, granule, and pill.
Abstract translation: 目的:提供聚乙二醇化共轭亚油酸(CLA)以增强CLA和d的溶解度,以提高生物相容性。 构成:具有高抗肥胖活性的药物组合物含有胆固醇化亚油酸(PCLA)。 药物组合物还含有载体,赋形剂和稀释剂。 食品组合物含有亚油酸作为活性成分。 组合物以片剂,胶囊,颗粒剂和丸剂的形式使用。